awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34478866-6D49400B-FB71-4726-9181-24FDB5F769D3
Q34478866-6D49400B-FB71-4726-9181-24FDB5F769D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34478866-6D49400B-FB71-4726-9181-24FDB5F769D3
Which outcome measures in SLE clinical trials best reflect medical judgment?
P2860
Q34478866-6D49400B-FB71-4726-9181-24FDB5F769D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34478866-6D49400B-FB71-4726-9181-24FDB5F769D3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
af215b07e6f78e421cccba38b864bec8313f152f
P2860
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study